ClinicalTrials.gg
CompletedNCT04734613Updated Mar 9, 2022

Tai Chi for Behavioral Modification Among Individuals With Metabolic Syndrome

An interventional study of Tai Chi exercise and self management in Metabolic Syndrome, sponsored by Chungnam National University. Completed at 1 site in Korea, Republic of. Per ClinicalTrials.gov, last updated 2022-03-09.

Sponsored by Chungnam National University · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
65
Allocation
Randomized
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 53 studies in Metabolic Syndrome with a site in Korea, Republic of — 4 open to participants now, 4 under way, none of them phase 3. Metabolic Syndrome · Korea, Republic of.

Enrollment
17th of 31
65 · median 67
Started
2020
with 1 other
No phase
17 of 53
1 open now
Registered
47th of 53
by date

Among the 53 studies in Metabolic Syndrome with a site in Korea, Republic of, this one is the 17th largest by enrollment of the 31 interventional ones that give a count, is one of 2 that started in 2020, is one of 17 with no phase, and was the 47th registered.

Metabolic Syndrome

2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.

Browse Metabolic Syndrome studies →

Open to participants now

4 of the 53 studies in Metabolic Syndrome with a site in Korea, Republic of are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 53 studies in Metabolic Syndrome with a site in Korea, Republic of, or all of them as a file.
02

Study summary

This is the randomized trial to explore the effect of behavioral modification program (Tai Chi vs. self management) on adults with metabolic syndrome. The outcome variables include health behavior, metabolic syndrome indicators, quality of life.

Read the detailed description
  1. venue: the individuals with diagnosis of metabolic syndrome are recruiting from university hospital outpatient clinic or primary clinic.
  2. inclusion criteria: diagnosed of metabolic syndrome, agree to participate either programs, no history of participating regular exercise program past 6 months.
  3. intervention: The behavioral modification program consisting of Tai Chi exercise (twice a week for 12 weeks) and self-management program (6 sessions every two weeks) is provided to the participants who randomly assigned to either group. Short form Yang style Tai Chi (16 movements) were led by trained Tai Chi practitioners, and self-management program were provided by nurse educators.
03

Conditions studied

  • Metabolic Syndrome

Browse trials for

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • diagnosis of metabolic syndrome
  • adults who agree to participate either behavioral modification programs for 12 weeks
  • be able to understand the questionnaire and follow the exercise or education program

Exclusion criteria

Exclusion Criteria:

  • who attend regular exercise program past 6 months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
65 participants (actual)

Study arms

  • Experimental
    Tai Chi intervention

    Tai Chi exercise intervention provided twice a week for one hour for 12 weeks

    Behavioral: Tai Chi exercise

  • Active comparator
    self management

    self management program provided 6 sessions (one hour per session) for 12 weeks

    Behavioral: self management

Interventions

  • BehavioralTai Chi exercise

    Yang style Tai Chi 16 movements

  • Behavioralself management

    health education and dietary counseling

06

What researchers measure

Primary outcomes

  1. Change in Cardiac health behavior scale

    cardiac health behaviors scale including exercise, diet, stress management, health responsibility, and smoking - 25 items in 4 point Likert scale

    Time frame: change from baseline health behavior score at 3 months

  2. Change in blood pressure

    systolic and diastolic blood pressure (mmHg)

    Time frame: change from baseline blood pressure at 3 months

  3. change in lipid profile

    high density lipoprotein(HDL), low density lipoprotein(LDL), total cholesterol, triglyceride

    Time frame: change from baseline lipid profile at 3 months

  4. Change in blood glucose

    HbA1C

    Time frame: change from baseline blood glucose at 3 months

  5. Change in abdominal obesity

    waist circumference (in centimeters) will be measured with indicator on upper hip bone

    Time frame: change from baseline waist circumference at 3 months

Secondary outcomes

  1. Change in quality of life

    health related quality of life (by SF36 v.2) to calculate mental and physical components in 100 points

    Time frame: change from baseline QOL score at 3 months

07

Study locations

1 site
  • Chungnam National University Hospital
    Daejeon, 34885, Korea, Republic of
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2020 to primary completion in Jan 2022, 13 months.

Of 627 non-industry interventional studies with no phase under Metabolic Syndrome, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 41. This study's 13 months is below that.

Counting every sponsor, half of 677 studies reached it within 20 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 26, 2021
First posted
Feb 2, 2021
StartActual
Dec 10, 2020
Primary completionActual
Jan 28, 2022
CompletionActual
Jan 28, 2022
Last update
Mar 9, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 9, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04734613
Lead sponsor
Chungnam National University
Collaborators
National Research Foundation, Singapore
Responsible party
Rhayun Song (Professor, Chungnam National University) — Principal investigator
First posted
Feb 2, 2021
Start date
Dec 10, 2020
Primary completion
Jan 28, 2022
Completion
Jan 28, 2022
Last update
Mar 9, 2022

Study contacts

Rhayun Song
principal investigator · Chungnam National University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion